| Type of Biological Sample |
Components / Analytes |
Examination Technique |
Examination Procedure |
Status |
| Clinical Pathology |
| | - Double Indicator Principle- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Protein -error--of-indicator- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Oxidase-peroxidase- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Nitroprusside Method- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Diazo Reaction- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Ebrlich- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Peroxidase Activity- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - pKa Change- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Diazonium- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| - Esterase Activity- Siemens Clinitek Status
| PL-CLM-IN-017 | Active
|
| | PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
- Ammonium phosphate Crystals
| PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
| | PL-CLM-PR-002 | Active
|
| PL-CLM-PR-002 | Active
|
| | PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| | PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| PL-CLM-PR-001 | Active
|
| Serology |
| | - Chemiluminescent Microparticle Immunoassay-ABBOTT Alinity CI
| PL-SER-PR-127 | Active
|
- Hepatitis C Ab, (Anti-HCV)
| PL-SER-PR-167 | Active
|
- Human Immuno Deficiency Virus Ag/Ab, (HIV-1/2)
| PL-SER-PR-157 | Active
|
| Hematology |
| - Segmented Neutrophils % (Neutro)
| | PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
- Segmented Neutrophils (Neutro)
| | PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
- White Blood Cell Count (WBC)
| | PL-HEM-IN-028 | Active
|
| - Sheath Flow Impendance Method
| PL-HEM-IN-028 | Active
|
| | PL-HEM-IN-028 | Active
|
| | PL-HEM-IN-028 | Active
|
- Red cell distribution width (RDW)
| PL-HEM-IN-028 | Active
|
- Mean Cell Hemoglobin (MCH)
| PL-HEM-IN-028 | Active
|
- Mean Cell Hemoglobin Concentration (MCHC)
| PL-HEM-IN-028 | Active
|
| PL-HEM-IN-028 | Active
|
- Mean Platelet Volume (MPV)
| PL-HEM-IN-028 | Active
|
- Platelet Count / THROMBOCYTES (PLT)
| - Sheath Flow Impedance Method
| PL-HEM-IN-028 | Active
|
| | | PL-HEM-IN-002 | Active
|
| - Photo-Optical Clot Detection Method
| PL-HEM-IN-002 | Active
|
- Prothrombin Time (PT) INR
| | PL-HEM-IN-002 | Active
|
- Activated Partial Thromboplastin Time (APTT)
| - Photo-Optical Clot Detection Method
| PL-HEM-IN-002 | Active
|
| Biochemistry |
| - Glycosylated/Glycated Hemoglobin
| - Enzymatic (Abott Alinity)
| PL-CLC-PR-259 | Active
|
| - Alanine transaminase, (ALT)
| - NADH (without P-5-P)-(Abott Alinity)
| PL-CLC-PR-225 | Active
|
- Aspartate Aminotransferase, (AST)
| PL-CLC-PR-232 | Active
|
| - Colorometric (BromocresolGreen)-(Abott Alinity)
| PL-CLC-PR-233 | Active
|
- Alkaline Phosphatase, (ALP)
| - Para-nitrophenyl phosphate (p-NPP)-(Abott Alinity)
| PL-CLC-PR-253 | Active
|
| - Enzymatic/Colorometric-(Abott Alinity)
| PL-CLC-PR-252 | Active
|
| - Diazonium Salt-(Abott Alinity)
| PL-CLC-PR-260 | Active
|
| - Diazo Reaction-(Abott Alinity)
| PL-CLC-PR-261 | Active
|
| | PL-CLC-PR-262 | Active
|
- Cholesterol, Total (CHOL)
| - Enzymatic-(Abott Alinity)
| PL-CLC-PR-263 | Active
|
| - N-acetyl-L-Cystine-(Abott Alinity)
| PL-CLC-PR-235 | Active
|
| - Ion-selective electrode diluted (Indirect)-(Abott Alinity)
| PL-CLC-PR-254 | Active
|
| - PEP Carboxylase-(Abott Alinity)
| PL-CLC-PR-234 | Active
|
| - Kinetic Alkaline Picrat-(Abott Alinity)
| PL-CLC-PR-264 | Active
|
- C-Reactive protein, (CRP)
| - Turbidimetric/Immunoturbidimetric-(Abott Alinity)
| PL-CLC-PR-265 | Active
|
- Low-Density Lipoprotein Cholesterol Direct, (LDL-D)
| - Measured Liquid Selective Detergent-(Abott Alinity)
| PL-CLC-PR-257 | Active
|
- Gamma-Glutamyl transferase, (GGT)
| - L-gamma-glutamyl-3-carboxy-4-nitroanilide substrate-(Abott Alinity)
| PL-CLC-PR-266 | Active
|
| | PL-CLC-PR-267 | Active
|
| - Ion-selective electrode diluted (Indirect)-(Abott Alinity)
| PL-CLC-PR-254 | Active
|
- Lactate Dehydrogenase, (LDH)
| - Lactate to Pyruvate-(Abott Alinity)
| PL-CLC-PR-256 | Active
|
| - Enzymatic-(Abott Alinity)
| PL-CLC-PR-268 | Active
|
| - Phosphomolybdate-(Abott Alinity)
| PL-CLC-PR-269 | Active
|
| | PL-CLC-PR-270 | Active
|
| - Glycerol phosphate oxidase-(Abott Alinity)
| PL-CLC-PR-271 | Active
|
- Cholesterol High Density Lipoprotein, (HDL)
| - Accelerator Selective detergent-(Abott Alinity)
| PL-CLC-PR-255 | Active
|
| | PL-CLC-PR-272 | Active
|
| | PL-CLC-PR-273 | Active
|
| - Methylresorufin-(Abott Alinity)
| PL-CLC-PR-258 | Active
|
| - Ion-selective electrode diluted (Indirect)-(Abott Alinity)
| PL-CLC-PR-254 | Active
|
| - Chemiluminescent Microparticle Immunoassay-(Abott Alinity)
| PL-IMN-PR-147 | Active
|
| PL-IMN-PR-148 | Active
|
- Free Triiodothyronine, (FT3)
| PL-IMN-PR-149 | Active
|
| PL-IMN-PR-150 | Active
|
- Follicle-Stimulating Hormone, (FSH)
| - Chemiluminescent Microparticle Immunoassay
| PL-IMN-PR-151 | Active
|
- Luteinizing Hormone, (LH)
| - Chemiluminescent Microparticle Immunoassay-(Abott Alinity)
| PL-IMN-PR-152 | Active
|
| PL-IMN-PR-153 | Active
|
| PL-IMN-PR-154 | Active
|
| PL-IMN-PR-155 | Active
|
- Thyroid Stimulating Hormone, (TSH)
| PL-IMN-PR-156 | Active
|
- Beta Human Chorionic Gonadotropin Quantitative, (B-HCG)
| PL-SER-PR-160 | Active
|
| PL-IMN-PR-157 | Active
|
- Heparinized Plasma/ Serum
| - Estimated glomerular filtration rate (eGFR)
| - Calculated-(Abott Alinity)
| PL-CLC-PR-274 | Active
|
| PL-CLC-PR-274 | Active
|
| | - Enzymatic (Hexokinase/G-6-PDH)-(Abott Alinity)
| PL-CLC-PR-236 | Active
|
- Glucose Tolerance Test 75g 1Hr
| PL-CLC-PR-236
PL-SA-IN-005 | Active
|